(NYSEMKT: AZTR) Azitra's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.65%.
Azitra's earnings in 2026 is -$11,814,265.On average, 4 Wall Street analysts forecast AZTR's earnings for 2026 to be -$6,771,678, with the lowest AZTR earnings forecast at -$11,266,698, and the highest AZTR earnings forecast at -$1,870,227. On average, 4 Wall Street analysts forecast AZTR's earnings for 2027 to be -$5,285,212, with the lowest AZTR earnings forecast at -$8,727,724, and the highest AZTR earnings forecast at -$1,530,185.
In 2027, AZTR is forecast to generate -$5,285,212 in earnings, with the lowest earnings forecast at -$8,727,724 and the highest earnings forecast at -$1,530,185.